Report: Biosimilar Market to Expand Rapidly

Monday, July 6, 2015

Source: SmartBrief

The worldwide market for biosimilars could reach $55 billion by 2020 and biologics could replace as much as 70% of the chemical drug market in the next 20 years, according to a report from GBI Research. GBI pointed to 642 biosimilar trials underway, with more than half focused on oncology and immunotherapy treatments.

View All News »